drugset / Trial / NCT02786043

PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses

NCT02786043

Phase 1 Completed 12 enrolled Lee's Pharmaceutical Limited
NaSingle-groupOpen-labelTreatment

Summary

The main objective is to evaluate the effect of Propionyl-L-Carnitine Hydrochloride on clinical pharmacokinetic characteristics and its effect of clinical pharmacokinetic characteristics and safety on healthy Chinese subjects to provide a basis for market authorization registration

Timeline

Start
2015-06
Primary completion
2015-11
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject LEVOCARNITINE PROPIONATE Small molecule 1 g Oral